Antimicrobial Agents and Chemotherapy · 2020 · 39 citations · 11 references
PharmacyPharmacokineticsPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyRespiratory PharmacotherapyAerosol TherapyDry Powder InhalersInhalation Dosage FormsInhalation Drug DeliveryPharmacokinetics Of AntimicrobialsPulmonary PharmacokineticsAerosolized AntibioticsAntimicrobial Inhalation TherapyDrug Formulation For InhalationDry Powder Inhaler PharmacokineticsForced Expiratory Volume DeclineInhaled AdministrationInhaled Antibiotic AdministrationVancomycin Toxicity
Methicillin-resistant Staphylococcus aureus (MRSA) has become a significant acute and chronic respiratory pathogen. While vancomycin is effective against MRSA, its relatively poor penetration into lung secretions and dose-limiting renal toxicity make it less effective in the respiratory setting. As inhaled administration of vancomycin would overcome these limitations, we developed a dry powder formulation suitable for inhalation (AeroVanc).
11
André C. Kalil, Mark L. Metersky, Michael Klompas et al. · Clinical Infectious Diseases · 2016 · 3.9K citations · Full text
Daniel J. Diekema, Michael A. Pfaller, Dee Shortridge et al. · Open Forum Infectious Diseases · 2019 · 217 citations · Full text
Life Sciences, Infectious Diseases, Antimicrobial Resistance +16
Charles Haworth, Diana Bilton, James D. Chalmers et al. · The Lancet Respiratory Medicine · 2019 · 205 citations · Full text